alankravitz

alankravitz's Recent CancerCompass Activity

• alankravitz has replied to a post on the message board

  On Jan 10, 2013 5:02 PMnewyork1234wrote: Hello, I read your posting and I am wondering if you have started or know of any advocacy groups focusing on the issue of access to anti-PD1.  Have you started any advocacy groups, or do you have a strategy for your campaign? I'm sorry that it has taken me this long to respond but this is an old post and I have't been back to it for some time. In answer to yo...

  February 01 at 1:58 PM view post

• alankravitz has replied to a post on the message board

  There is no known relationship between anti-PD-1 and BRAF, it works in an entirely different way.

  September 08 at 4:25 AM view post

• alankravitz has replied to a post on the message board

  Trial # 15400 at Moffitt is a Phase 1 trial of anti-PD-1 with a Peptide Vaccine. It os one of several that combine anti-PD-1 with other agents. All the information about results that I have seen comes from patients, some who have seen excellent results. There are, indeed, no Phase 2 or 3 trials as yet but the original Stage 1B trial that I participated was expanded. The results from that study have led Bristol Meyers...

  September 06 at 1:27 PM view post

• alankravitz has created a new message board discussion

  I have been a participant in the Phase 1B anti-PD-1 (MDX-1106, BMS-936588) trial for 4 years and have been NED for over 3. As a melanoma advocate, I follow postings on the many melanoma related sites and forums: over the past few months there have been a vast number of postings by patients for whom recently approved therapies no longer keep melanoma in check. They are crying out for anti-PD-1 and, especially t...

  September 04 at 1:19 AM view discussion

• alankravitz has created a new message board discussion

  Bristol-Meyers Squibb is launching several clinical trials for their anti-PD-1 product, BMS-936558, for NSCLC. I was a participant in their 1B trial for melanoma, NSCLC and renal cell cancers, In that trial they reported an 18% response rate for NSCLC and slightly higher response rates for the other indications. The oncology community has been very enthusiastic about this immunotherapy since  early results of th...

  August 30 at 1:15 PM view discussion

• alankravitz has created a new message board discussion

  The recent movie,"You will Cry and Smile," directed by Kevin Macdonald seems to resurrect the Urban Legend that Marley died from an acral lentiginous melanoma that resulted from a football injury to the big toe on his right foot. He did die from metastatic melanoma that had its primary lesion on that toe but the injury and the trauma that resulted were only what caused him to seek medical attention. People of co...

  April 29, 2012 view discussion

• alankravitz has created a new message board discussion

  I am a Stage IV survivor looking for others who have the time and effort to participate in an advocacy effort modeled upon the one that helped to facilitate the rapid development of treatments for HIV and Aids. The effort would involve participation in conferences, FDA and NIH review efforts and local support organizations in order to support change in the way in which new therapies and diagnostics are developed, tes...

  June 11, 2011 view discussion